Clinical Trials Logo

Clinical Trial Summary

To explore and analyze the relationship between intestinal flora changes and the efficacy of individualized immunotherapy in patients with upper gastrointestinal cancer, and to find new biomarkers to predict the efficacy of immunotherapy, bringing new breakthroughs in tumor diagnosis and treatment.


Clinical Trial Description

1. Compare the composition of intestinal flora of patients before and after immunotherapy and in patients with different therapeutic effects of immunotherapy. 2. Combine the results above with the patient's blood sample, which is carried out from the metabolic level. 3. Combine the pathological data of the patient to determine the staging and pathological types, and use blood samples to detect metabolites to find out different metabolites. 4. the metabolic data and the flora data are associated with the analysis to find the bacteria species with higher correlation with the differential metabolites to guide the subsequent animal experiments. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05065515
Study type Observational
Source Xijing Hospital
Contact Jianjun Yang, Dr
Phone 0086-13572533693
Email [email protected]
Status Not yet recruiting
Phase
Start date October 2021
Completion date June 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04991792 - Effect of an Infant Formula With Synbiotics in Infants Born Via Caesarean Section N/A
Completed NCT02151825 - Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects N/A
Completed NCT01545219 - A Study of a Prebiotic, a Probiotic and a Synbiotic Upon the Gut Microbiota and Immune Response of Healthy Volunteers N/A
Enrolling by invitation NCT05057039 - The Study of Gut Microbiota in Hypertensive Patients
Not yet recruiting NCT05039060 - Modified MAC Diet and Gut Microbiota in CRC Patients N/A
Completed NCT03746158 - Interindividual Variation in Excretion of Curcumin N/A
Active, not recruiting NCT03266055 - Effects of Blueberry on Gut Microbiota and Metabolic Syndrome N/A
Completed NCT04960878 - The Effect of Synbiotics on the Upper Respiratory Tract Infection N/A
Recruiting NCT04120051 - The SIMBA Project - The Effect of a Prebiotic Supplement on Glucose Metabolism and Gut Microbiota in Obese Adults N/A
Completed NCT03293693 - Intake of Beta-glucan and Postprandial Regulation of Blood Glucose Metabolism in Healthy Subjects N/A
Completed NCT02207140 - Effect of Multi-species Probiotic HOWARU® Restore, on Gut Microbiota of Elderly Phase 0
Recruiting NCT04203459 - The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation
Recruiting NCT03259685 - Effect of Non-nutritive Sweeteners of High Sugar Sweetened Beverages on Metabolic Health and Gut Microbiome N/A
Completed NCT03203044 - Impact of Soylent Consumption on Human Microbiome Composition N/A
Not yet recruiting NCT05008120 - Gut Microbiota in Major Depressive Disorders With and Without Rapid Eye Movement Behavior Disorder
Completed NCT04303286 - The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma
Not yet recruiting NCT04947410 - Intestinal Dysbiosis During Obstructive Sleep Apnea Syndrome N/A
Not yet recruiting NCT04316910 - Characterisation of Gut Microbiota in Patients Undergoing Gastrointestinal Surgery With Postoperative Delirium (GIM-POD)
Recruiting NCT03667495 - The Relationship Between Postoperative Changes of Oral and Intestinal Flora and Prognosis
Completed NCT02929459 - Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota Phase 2